PLoS ONE (Jan 2024)

Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model

  • Filip Stanicic,
  • Vladimir Zah,
  • Dimitrije Grbic,
  • Debra De Angelo

Journal volume & issue
Vol. 19, no. 11

Abstract

Read online

No abstracts available.